INDI MOLECULAR LAUNCHES WITH $1.5 MILLION SEED ROUND LED BY INTERWEST PARTNERS
September 20, 2013
SEATTLE and CULVER CITY, CA – Indi Molecular, which pioneered a synthetic replacement for antibodies, today announced that it has raised a $1.5 million seed round led by InterWest Partners and joined by several angel investors. The funds will be used to further develop PCC (protein catalyzed capture) agent technology: a breakthrough process that produces [...]
SeraCare Life Sciences Expands R&D Facilities
September 20, 2013
MILFORD, Mass. -- SeraCare Life Sciences, a manufacturer of life sciences tools, bulk plasma, and quality controls for diagnostic companies and clinical laboratories, announced an expansion of its research and manufacturing facilities at its Milford, Massachusetts headquarters. The addition of the state-of-the-art facility was driven by new companion diagnostic manufacturing opportunities with key diagnostic partners [...]
September 19, 2013
FARMINGDALE, N.Y. -- Cemtrex (OTC: CTEI) announced it signed a distribution agreement for process oil and gas analyzer systems, in the U.S. market, with SensEvolution® a division of BAGGI®. This signing comes at a favorable time as the U.S. continues to expand its domestic oil production. Increasing production of crude oil from shale deposits in [...]
September 19, 2013
CREEDMOOR, NORTH CAROLINA – AirClean® Systems microprocessor-controlled PCR workstations reduce risk of sample contamination during DNA/RNA amplification. AirClean® Systems AC600 Series PCR workstations are designed as application solutions for the manipulation and amplification of DNA and RNA. These PCR workstations are available in 24’’, 32’’, and 48’’ widths. Additional features include built-in 254 nm ultraviolet [...]
Agilent Technologies to Separate into Two Industry-Leading Public Companies
September 19, 2013
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced plans to separate into two publicly traded companies: one in life sciences, diagnostics and applied markets (LDA) that will retain the Agilent name, and the other that will be comprised of Agilent's current portfolio of electronic measurement (EM) products. The separation is expected to [...]
September 19, 2013
REDWOOD CITY, Calif. -- Illumina, Inc. (NASDAQ: ILMN) today announced Verinata Health, an Illumina company, published additional peer-reviewed data1 showing that Verinata's non-invasive verifi® prenatal test2 correctly detects aneuploidies across all test samples, even for patients with very low fetal fractions (cell-free DNA fragments in maternal blood contributed from the fetus). The publication also documented [...]
Agilent Technologies Announces Collaboration with Florey Institute of Neuroscience and Mental Health
September 19, 2013
MELBOURNE, Australia -- Agilent Technologies Inc. (NYSE: A) today announced a collaboration with the Florey Institute of Neuroscience and Mental Health that will allow scientists to detect and measure metals at the protein level directly from tissue in neurodegenerative diseases such as motor neuron, Parkinson's and Alzheimer's. For scientists and researchers, the ability to monitor [...]
September 19, 2013
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced it has combined its Life Sciences Group with its Diagnostics and Genomics business, naming Lars Holmkvist the new group's president and senior vice president of Agilent, effective immediately. Holmkvist was previously president of the Diagnostics and Genomics Group and senior vice president of Agilent. [...]
PAC Instruments Comply with New CEN Standard, EN 16329
September 19, 2013
Houston, TX., USA – Both PAC’s Herzog HCP 842 and ISL FPP 5Gs now fully comply with the new standard, EN 16329, “Determination of CFPP for Diesel and Domestic Heating Fuels – Linear Cooling Bath Method” recently released by CEN (European Committee for Standardization). The EN 16329 is now also listed in the EN 590 [...]
September 19, 2013
NEW YORK, Sept. 19, 2013 /PRNewswire/ -- Exosome Diagnostics today announced it has entered into a collaboration agreement with Eli Lilly and Company (NYSE: LLY) for biomarker discovery and validation using Exosome Diagnostics proprietary EXO50 nucleic acid extraction kit. Under the agreement, Lilly will gain early access to Exosome Diagnostics technology to help identify key [...]
